MIM
IDYA icon

Monashee Investment Management’s IDEAYA Biosciences IDYA Stock Holding History

Monashee Investment Management’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-35,000
Closed -$1.11M – 64
2024
Q3 		$1.11M Buy
+35,000
New +$1.33M 0.12% 93
2022
Q4 		– Sell
-60,000
Closed -$895K – 54
2022
Q3 		$895K Buy
+60,000
New +$779K 0.33% 39
2020
Q3 		– Sell
-140,000
Closed -$1.99M – 212
2020
Q2 		$1.99M Buy
+140,000
New +$1.1M 0.3% 101
2019
Q3 		– Sell
-35,546
Closed -$354K – 149
2019
Q2 		$354K Buy
+35,546
New +$387K 0.09% 128

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Monashee Investment Management's IDYA Position: Q4 2024 in Review

Monashee Investment Management sold out of IDEAYA Biosciences (IDYA) in Q4 2024, closing a stake of 35,000 shares — an estimated $1.11M sold.

Monashee Investment Management first reported a position in IDYA in Q2 2019 and held it in 4 quarters. The position peaked at $1.99M in Q2 2020. 206 funds tracked by Wall St. Rank hold IDYA as of Q4 2024.

  • Monashee Investment Management reported no remaining IDEAYA Biosciences position as of Q4 2024 after selling out during the quarter.
  • Monashee Investment Management sold 35,000 IDEAYA Biosciences shares in Q4 2024, an estimated $1.11M.
  • Monashee Investment Management first reported a position in IDEAYA Biosciences in Q2 2019 and held it in 4 quarters.
  • Monashee Investment Management's IDEAYA Biosciences position peaked at $1.99M in Q2 2020.
  • 206 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2024.

Based on Monashee Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.